Clinical Trial Update: Personalized Therapeutic Neuromodulation for Anhedonic Depression [NA]

View source ↗

Summary

This update reports the completion of a clinical trial investigating personalized neuromodulation for treatment-resistant depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Snippet

Sponsor: Stanford University | Conditions: Treatment Resistant Depression | NA | Status: COMPLETED